In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house roundup: Trump trade war uncertainty; 5G guidance not usable; Senate eligibility hearing takeaways; unitary SPC overview

Money

Managing IP rounds up the latest news and analysis from patent-focused businesses



Drugs

Trump trade war is “lose-lose situation” for IP in China and the US

With Trump blacklisting Huawei from the US, telecom companies tell Patent Strategy they are fearful that a trade war escalation will affect IP and are uncertain how to prepare for such an outcome. Read More... 

Diverging SEP guidelines will have little to no impact on negotiations say stakeholders

Reacting to the publication of new SEP licensing guidance, counsel at Audi, Philips and BSH Home Appliances explain how the documents will affect them and that they would like to see a more united direction emerge. Read more... 

Patent eligibility hearings “belied depth of opposition to Section 101 change”

Industry speakers from the Senate IP Subcommittee hearings last month tell Patent Strategy how they thought the inquiry was conducted and what needs to happen next to ensure US innovation is protected. Read more... 

Unitary SPCs: How, where and when they could work

Industry sources at the Pharmaceutical Patent Term Extension conference in Munich question the practical details of unitary SPCs, including granting procedure, enforcement, and judicial review. Read more... 





more from across site and SHARED ros bottom lb

More from across our site

News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Gift this article